Duffaud F - Search Results

1

Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.

Dales JP, Garcia S, Bonnier P, Duffaud F, Meunier-Carpentier S, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C. Dales JP, et al. Among authors: duffaud f. Int J Oncol. 2003 Feb;22(2):391-7. Int J Oncol. 2003. PMID: 12527939

2

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.

Dales JP, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O, Lavaut MN, Allasia C, Charpin C. Dales JP, et al. Among authors: duffaud f. Am J Clin Pathol. 2003 Mar;119(3):374-80. doi: 10.1309/1kf54l6rb625556w. Am J Clin Pathol. 2003. PMID: 12645339

3

[Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].

Dales JP, Garcia S, Bonnier P, Duffaud F, Carpentier S, Djemli A, Ramuz O, Andrac L, Lavaut M, Allasia C, Charpin C. Dales JP, et al. Among authors: duffaud f. Ann Pathol. 2003 Sep;23(4):297-305. Ann Pathol. 2003. PMID: 14597894 French.

4

Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.

Salas S, Bartoli C, Deville JL, Gaudart J, Fina F, Calisti A, Bollini G, Curvale G, Gentet JC, Duffaud F, Figarella-Branger D, Bouvier C. Salas S, et al. Among authors: duffaud f. Virchows Arch. 2007 Dec;451(6):999-1007. doi: 10.1007/s00428-007-0474-8. Epub 2007 Sep 5. Virchows Arch. 2007. PMID: 17786474

5

Gastrointestinal stromal tumors: biology and treatment.

Duffaud F, Blay JY. Duffaud F, et al. Oncology. 2003;65(3):187-97. doi: 10.1159/000074470. Oncology. 2003. PMID: 14657591 Review.

6

Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.

Salas S, Deville JL, Giorgi R, Pignon T, Bagarry D, Barrau K, Zanaret M, Giovanni A, Bourgeois A, Favre R, Duffaud F. Salas S, et al. Among authors: duffaud f. Radiother Oncol. 2008 May;87(2):195-200. doi: 10.1016/j.radonc.2008.02.011. Epub 2008 Mar 14. Radiother Oncol. 2008. PMID: 18342966

7

Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.

Salas S, Jézéquel P, Campion L, Deville JL, Chibon F, Bartoli C, Gentet JC, Charbonnel C, Gouraud W, Voutsinos-Porche B, Brouchet A, Duffaud F, Figarella-Branger D, Bouvier C. Salas S, et al. Among authors: duffaud f. Int J Cancer. 2009 Aug 15;125(4):851-60. doi: 10.1002/ijc.24457. Int J Cancer. 2009. PMID: 19449377

8

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

Casali PG, Le Cesne A, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Adenis A, Hartmann JT, Duffaud F, Goldstein D, Broto JM, Gronchi A, Dei Tos AP, Marréaud S, van der Graaf WT, Zalcberg JR, Litière S, Blay JY. Casali PG, et al. Among authors: duffaud f. J Clin Oncol. 2015 Dec 20;33(36):4276-83. doi: 10.1200/JCO.2015.62.4304. Epub 2015 Nov 16. J Clin Oncol. 2015. PMID: 26573069 Clinical Trial.

9

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.

Boughzala-Bennadji R, Stoeckle E, Le Péchoux C, Méeus P, Honoré C, Attal J, Duffaud F, De Pinieux G, Bompas E, Thariat J, Leroux A, Bertucci F, Isambert N, Delcambre C, Blay JY, Sunyach MP, Coindre JM, Sargos P, Penel N, Bonvalot S. Boughzala-Bennadji R, et al. Among authors: duffaud f. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):399-406. doi: 10.1016/j.ijrobp.2018.05.055. Epub 2018 Jun 2. Int J Radiat Oncol Biol Phys. 2018. PMID: 30191871

10

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.

Neron M, Sajous C, Thezenas S, Piperno-Neumann S, Reyal F, Laé M, Chakiba C, Penel N, Ryckewaert T, Honoré C, Bertucci F, Monneur A, Salas S, Duffaud F, Saada-Bouzid E, Isambert N, Brahmi M, Ray-Coquard I, Blay JY, Firmin N; French Sarcoma Group (GSF-GETO). Neron M, et al. Among authors: duffaud f. Ann Surg Oncol. 2020 May;27(5):1693-1699. doi: 10.1245/s10434-019-08097-x. Epub 2019 Nov 26. Ann Surg Oncol. 2020. PMID: 31773519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters